244 related articles for article (PubMed ID: 24488406)
41. Difference in spectral power density of sleep electroencephalography between individuals without insomnia and frequent hypnotic users with insomnia complaints.
Kang JM; Cho SE; Moon JY; Kim SI; Kim JW; Kang SG
Sci Rep; 2022 Feb; 12(1):2117. PubMed ID: 35136089
[TBL] [Abstract][Full Text] [Related]
42. Sleep EEG power spectra, insomnia, and chronic use of benzodiazepines.
Bastien CH; LeBlanc M; Carrier J; Morin CM
Sleep; 2003 May; 26(3):313-7. PubMed ID: 12749551
[TBL] [Abstract][Full Text] [Related]
43. The effects of substituting zopiclone in withdrawal from chronic use of benzodiazepine hypnotics.
Pat-Horenczyk R; Hacohen D; Herer P; Lavie P
Psychopharmacology (Berl); 1998 Dec; 140(4):450-7. PubMed ID: 9888621
[TBL] [Abstract][Full Text] [Related]
44. Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study.
Krystal AD; Erman M; Zammit GK; Soubrane C; Roth T;
Sleep; 2008 Jan; 31(1):79-90. PubMed ID: 18220081
[TBL] [Abstract][Full Text] [Related]
45. An assessment of quality of sleep and the use of drugs with sedating properties in hospitalized adult patients.
Frighetto L; Marra C; Bandali S; Wilbur K; Naumann T; Jewesson P
Health Qual Life Outcomes; 2004 Mar; 2():17. PubMed ID: 15040803
[TBL] [Abstract][Full Text] [Related]
46. Zopiclone's residual effects on actual driving performance in a standardized test: a pooled analysis of age and sex effects in 4 placebo-controlled studies.
Leufkens TR; Vermeeren A
Clin Ther; 2014 Jan; 36(1):141-50. PubMed ID: 24360801
[TBL] [Abstract][Full Text] [Related]
47. Polysomnographic study of intermittent zolpidem treatment in primary sleep maintenance insomnia.
Parrino L; Smerieri A; Giglia F; Milioli G; De Paolis F; Terzano MG
Clin Neuropharmacol; 2008; 31(1):40-50. PubMed ID: 18303490
[TBL] [Abstract][Full Text] [Related]
48. Noise-induced sleep maintenance insomnia: hypnotic and residual effects of zaleplon.
Stone BM; Turner C; Mills SL; Paty I; Patat A; Darwish M; Danjou P
Br J Clin Pharmacol; 2002 Feb; 53(2):196-202. PubMed ID: 11851645
[TBL] [Abstract][Full Text] [Related]
49. Sensitivity of cyclic alternating pattern to prolonged pharmacotherapy: a 5-week study evaluating zolpidem in insomniac patients.
Terzano MG; Parrino L; Boselli M; Spaggiari MC; Di Giovanni G; Smerieri A
Clin Neuropharmacol; 1997 Oct; 20(5):447-54. PubMed ID: 9331522
[TBL] [Abstract][Full Text] [Related]
50. Multidrug comparison (lorazepam, triazolam, zolpidem, and zopiclone) in situational insomnia: polysomnographic analysis by means of the cyclic alternating pattern.
Parrino L; Boselli M; Spaggiari MC; Smerieri A; Terzano MG
Clin Neuropharmacol; 1997 Jun; 20(3):253-63. PubMed ID: 9197949
[TBL] [Abstract][Full Text] [Related]
51. Long-term Use of Z-Hypnotics and Co-medication with Benzodiazepines and Opioids.
Sakshaug S; Handal M; Hjellvik V; Berg C; Ripel Å; Gustavsen I; Mørland J; Skurtveit S
Basic Clin Pharmacol Toxicol; 2017 Mar; 120(3):292-298. PubMed ID: 27717229
[TBL] [Abstract][Full Text] [Related]
52. Efficacy of L-846 in patients with insomnia: evaluation by polysomnography.
Sakamoto T; Uchimura N; Mukai M; Mizuma H; Shirakawa SI; Nakazawa Y
Psychiatry Clin Neurosci; 1998 Apr; 52(2):156-7. PubMed ID: 9628124
[TBL] [Abstract][Full Text] [Related]
53. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
Roth T; Soubrane C; Titeux L; Walsh JK;
Sleep Med; 2006 Aug; 7(5):397-406. PubMed ID: 16815744
[TBL] [Abstract][Full Text] [Related]
54. Insomnia, hypnotic use, and health-related quality of life in a nationally representative sample.
Scalo J; Desai P; Rascati K
Qual Life Res; 2015 May; 24(5):1223-33. PubMed ID: 25432884
[TBL] [Abstract][Full Text] [Related]
55. Effects of pregabalin in patients with hypnotic-dependent insomnia.
Cho YW; Song ML
J Clin Sleep Med; 2014 May; 10(5):545-50. PubMed ID: 24812540
[TBL] [Abstract][Full Text] [Related]
56. Persistent insomnia in chronic hypnotic users presenting to a sleep medical center: a retrospective chart review of 137 consecutive patients.
Krakow B; Ulibarri VA; Romero E
J Nerv Ment Dis; 2010 Oct; 198(10):734-41. PubMed ID: 20921864
[TBL] [Abstract][Full Text] [Related]
57. Dose determinants of rebound insomnia.
Roehrs TA; Zorick FJ; Wittig RM; Roth T
Br J Clin Pharmacol; 1986 Aug; 22(2):143-7. PubMed ID: 3530302
[TBL] [Abstract][Full Text] [Related]
58. Effect of withdrawal from long-term use of temazepam, zopiclone or zolpidem as hypnotic agents on cognition in older adults.
Puustinen J; Lähteenmäki R; Polo-Kantola P; Salo P; Vahlberg T; Lyles A; Neuvonen PJ; Partinen M; Räihä I; Kivelä SL
Eur J Clin Pharmacol; 2014 Mar; 70(3):319-29. PubMed ID: 24337417
[TBL] [Abstract][Full Text] [Related]
59. Hypnotics, sleep, and mortality in elderly people.
Rumble R; Morgan K
J Am Geriatr Soc; 1992 Aug; 40(8):787-91. PubMed ID: 1634722
[TBL] [Abstract][Full Text] [Related]
60. Hypnotic discontinuation in chronic insomnia: impact of psychological distress, readiness to change, and self-efficacy.
Belleville G; Morin CM
Health Psychol; 2008 Mar; 27(2):239-48. PubMed ID: 18377143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
